A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor

被引：15
|
作者：
Leroy, L. [1 ]
Lafarge, X. [2 ]
Blouin, L. [2 ]
Bijou, F. [3 ]
Durrieu, F. [4 ]
Olivier, E. [5 ]
Le Moulec, S. [1 ]
机构：
[1] Bergonie Inst, Dept Med Oncol, Bordeaux, France
[2] EFS, INSERM, Unit 1035, Bordeaux, France
[3] Bergonie Inst, Dept Med Hematol, Bordeaux, France
[4] Bergonie Inst, Dept Biol Hematol, Bordeaux, France
[5] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷 / 02期
关键词：
IPILIMUMAB-INDUCED THROMBOCYTOPENIA;
D O I：
10.1093/annonc/mdx693
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：514 / 515
页数：3
相关论文
共 50 条
  • [1] Expression of PD-L1 on renal tubular epithelial cells and functional role of PD-L1/PD-1 pathway in immune-mediated injury
    Wahl, PR
    Le Hir, M
    Heemann, U
    Wang, MH
    Schoop, R
    Wuthrich, RP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 174A - 174A
  • [2] PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review
    Moore, Donald C.
    Elmes, Joseph B.
    Arnall, Justin R.
    Strassel, Scott A.
    Patel, Jai N.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 129
  • [3] Comparison Between Immune-Mediated Pneumonitis and Pneumonia in Patients Treated with PD-1/PD-L1 Therapy
    Kim, M. Y.
    Kim, C.
    Kim, Y. J.
    Choi, C.
    Kim, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S594 - S595
  • [4] CTC immune escape mediated by PD-L1
    Wang, Xuefei
    Sun, Qiang
    Liu, Qiaofei
    Wang, Changjun
    Yao, Ru
    Wang, Yimin
    MEDICAL HYPOTHESES, 2016, 93 : 138 - 139
  • [5] Treatment with PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors. Immune-mediated side effects
    Grimm, M. -O.
    Oppel-Heuchel, H.
    Foller, S.
    UROLOGE, 2018, 57 (05): : 543 - 551
  • [6] PD-L1 expression in the CNS mitigates immune-mediated damage and morbidity at the cost of viral persistence
    Phares, Timothy W.
    Atkinson, Roscoe
    Stohlman, Stephen A.
    Bergmann, Cornelia C.
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [7] CANINE IMMUNE-MEDIATED THROMBOCYTOPENIA .1.
    MACKIN, A
    COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN, 1995, 17 (03): : 353 - &
  • [8] Macrocyclic Peptide Inhibitor of PD-1/PD-L1 Immune Checkpoint
    Magiera-Mularz, Katarzyna
    Kuska, Katarzyna
    Skalniak, Lukasz
    Grudnik, Przemyslaw
    Musielak, Bogdan
    Plewka, Jacek
    Kocik, Justyna
    Stec, Malgorzata
    Weglarczyk, Kazimierz
    Sala, Dominik
    Wladyka, Benedykt
    Siedlar, Maciej
    Holak, Tad A.
    Dubin, Grzegorz
    ADVANCED THERAPEUTICS, 2021, 4 (02)
  • [9] Immune Escape Mediated by Exosomal PD-L1 in Cancer
    Lawler, Sean E.
    Nowicki, Michal O.
    Ricklefs, Franz L.
    Chiocca, E. Antonio
    ADVANCED BIOSYSTEMS, 2020, 4 (12)
  • [10] IMMUNE-MEDIATED THROMBOCYTOPENIA IN A DOG
    FELDMAN, BF
    THOMASON, KJ
    JAIN, NC
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1988, 18 (01) : 258 - 260
12345